Journal
JOURNAL OF CHEMOTHERAPY
Volume 14, Issue 5, Pages 431-443Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1179/joc.2002.14.5.431
Keywords
anticancer; antimicrobial; blood; DNA; malaria; Methylene Blue; neuroleptic
Ask authors/readers for more resources
Since it was first synthesised in 1876, Methylene Blue (MB) has found uses in many different areas of clinical medicine, ranging from dementia to cancer chemotherapy. In addition, MB formed the basis of antimicrobial chemotherapy - particularly in the area of antimalarials - and eventually led to the discovery of the neuroleptic drug families. More recently, the photosensitising potential of MB and its congeners has been recognised, and these are being applied in various antimicrobial fields, especially that of blood disinfection. The range of activities of MB is due to the combination of its simple chemical structure and facility for oxidation-reduction reactions in situ.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available